Kurs
+0,13%
Likviditet
4,73 MSEK
Kalender
Tid* | ||
2025-11-07 | 08:00 | Kvartalsrapport 2025-Q3 |
2025-08-08 | 08:00 | Kvartalsrapport 2025-Q2 |
2025-05-22 | N/A | Årsstämma |
2025-05-09 | 08:00 | Kvartalsrapport 2025-Q1 |
2025-02-21 | 08:00 | Bokslutskommuniké 2024 |
2024-11-08 | - | Kvartalsrapport 2024-Q3 |
2024-08-16 | - | Kvartalsrapport 2024-Q2 |
2024-05-23 | - | X-dag ordinarie utdelning RAY B 0.70 SEK |
2024-05-23 | - | X-dag bonusutdelning RAY B 1.3 |
2024-05-22 | - | Årsstämma |
2024-05-17 | - | Kvartalsrapport 2024-Q1 |
2024-02-23 | - | Bokslutskommuniké 2023 |
2023-11-17 | - | Kvartalsrapport 2023-Q3 |
2023-08-25 | - | Kvartalsrapport 2023-Q2 |
2023-05-26 | - | X-dag ordinarie utdelning RAY B 0.00 SEK |
2023-05-25 | - | Årsstämma |
2023-05-17 | - | Kvartalsrapport 2023-Q1 |
2023-02-28 | - | Bokslutskommuniké 2022 |
2022-11-29 | - | Kvartalsrapport 2022-Q3 |
2022-08-29 | - | Kvartalsrapport 2022-Q2 |
2022-05-27 | - | X-dag ordinarie utdelning RAY B 0.00 SEK |
2022-05-25 | - | Årsstämma |
2022-05-18 | - | Kvartalsrapport 2022-Q1 |
2022-02-23 | - | Bokslutskommuniké 2021 |
2021-11-18 | - | Kvartalsrapport 2021-Q3 |
2021-08-25 | - | Kvartalsrapport 2021-Q2 |
2021-05-27 | - | X-dag ordinarie utdelning RAY B 0.00 SEK |
2021-05-26 | - | Årsstämma |
2021-05-05 | - | Kvartalsrapport 2021-Q1 |
2021-02-23 | - | Bokslutskommuniké 2020 |
2020-11-18 | - | Kvartalsrapport 2020-Q3 |
2020-08-26 | - | Kvartalsrapport 2020-Q2 |
2020-07-01 | - | X-dag ordinarie utdelning RAY B 0.00 SEK |
2020-06-30 | - | Årsstämma |
2020-05-05 | - | Kvartalsrapport 2020-Q1 |
2020-02-14 | - | Bokslutskommuniké 2019 |
2019-11-14 | - | Kvartalsrapport 2019-Q3 |
2019-08-20 | - | Kvartalsrapport 2019-Q2 |
2019-05-22 | - | X-dag ordinarie utdelning RAY B 0.00 SEK |
2019-05-21 | - | Årsstämma |
2019-05-09 | - | Kvartalsrapport 2019-Q1 |
2019-02-20 | - | Bokslutskommuniké 2018 |
2018-11-15 | - | Kvartalsrapport 2018-Q3 |
2018-08-23 | - | Kvartalsrapport 2018-Q2 |
2018-05-31 | - | X-dag ordinarie utdelning RAY B 0.00 SEK |
2018-05-29 | - | Årsstämma |
2018-05-09 | - | Kvartalsrapport 2018-Q1 |
2018-02-15 | - | Bokslutskommuniké 2017 |
2017-11-22 | - | Kvartalsrapport 2017-Q3 |
2017-08-24 | - | Kvartalsrapport 2017-Q2 |
2017-05-24 | - | X-dag ordinarie utdelning RAY B 0.00 SEK |
2017-05-23 | - | Årsstämma |
2017-05-19 | - | Kvartalsrapport 2017-Q1 |
2017-02-17 | - | Bokslutskommuniké 2016 |
2016-11-18 | - | Kvartalsrapport 2016-Q3 |
2016-08-25 | - | Kvartalsrapport 2016-Q2 |
2016-05-18 | - | X-dag ordinarie utdelning RAY B 0.25 SEK |
2016-05-17 | - | Årsstämma |
2016-05-12 | - | Kvartalsrapport 2016-Q1 |
2016-02-18 | - | Bokslutskommuniké 2015 |
2015-11-25 | - | Kvartalsrapport 2015-Q3 |
2015-08-28 | - | Kvartalsrapport 2015-Q2 |
2015-05-29 | - | X-dag ordinarie utdelning RAY B 0.00 SEK |
2015-05-28 | - | Årsstämma |
2015-05-08 | - | Kvartalsrapport 2015-Q1 |
2015-02-12 | - | Bokslutskommuniké 2014 |
2014-11-27 | - | Kvartalsrapport 2014-Q3 |
2014-08-27 | - | Kvartalsrapport 2014-Q2 |
2014-05-28 | - | X-dag ordinarie utdelning RAY B 0.00 SEK |
2014-05-27 | - | Årsstämma |
2014-05-16 | - | Kvartalsrapport 2014-Q1 |
2014-02-13 | - | Bokslutskommuniké 2013 |
2013-11-27 | - | Kvartalsrapport 2013-Q3 |
2013-08-28 | - | Kvartalsrapport 2013-Q2 |
2013-05-23 | - | X-dag ordinarie utdelning RAY B 0.00 SEK |
2013-05-22 | - | Årsstämma |
2013-05-16 | - | Kvartalsrapport 2013-Q1 |
2013-02-14 | - | Bokslutskommuniké 2012 |
2012-11-16 | - | Kvartalsrapport 2012-Q3 |
2012-08-28 | - | Kvartalsrapport 2012-Q2 |
2012-05-31 | - | X-dag ordinarie utdelning RAY B 0.00 SEK |
2012-05-30 | - | Årsstämma |
2012-05-23 | - | Kvartalsrapport 2012-Q1 |
2012-02-16 | - | Bokslutskommuniké 2011 |
2011-11-24 | - | Kvartalsrapport 2011-Q3 |
2011-05-26 | - | X-dag ordinarie utdelning RAY B 0.50 SEK |
2011-05-25 | - | Årsstämma |
2011-05-04 | - | Kvartalsrapport 2011-Q1 |
2011-02-18 | - | Bokslutskommuniké 2010 |
2010-11-12 | - | Kvartalsrapport 2010-Q3 |
2010-08-27 | - | Kvartalsrapport 2010-Q2 |
2010-05-26 | - | X-dag ordinarie utdelning RAY B 0.50 SEK |
2010-05-25 | - | Årsstämma |
2010-05-11 | - | Kvartalsrapport 2010-Q1 |
2009-11-20 | - | Kvartalsrapport 2009-Q3 |
2009-08-27 | - | Kvartalsrapport 2009-Q2 |
2009-05-27 | - | X-dag ordinarie utdelning RAY B 0.00 SEK |
2009-05-26 | - | Årsstämma |
2009-05-15 | - | Kvartalsrapport 2009-Q1 |
2008-06-25 | - | Split RAY B 1:3 |
2003-06-10 | - | Split RAY B 20:1 |
Beskrivning
Land | Sverige |
---|---|
Lista | Mid Cap Stockholm |
Sektor | Hälsovård |
Industri | Medicinteknik |
RaySearch Laboratories AB (publ) is proud to announce that the number of radiotherapy centers in Japan that are using RayStation for treatment planning has surpassed 200. In terms of number of centers, Japan is RaySearch's second largest market.
Since the launch in 2009, RayStation has been sold to more than 900 cancer centers all over the world. The United States has the largest number of RayStation centers, with more than 250 customers. In third place, after Japan, is China, where around 80 centers have RayStation.
In 2014, the University of Tokyo Hospital was the first center to introduce RayStation in Japan. Today, 63 university hospitals and 20 advanced research institutes have adopted the software and have played a significant role in introducing the treatment planning system to the Japanese market.
During the fourth quarter of 2022, 13 new RayStation customers were added in Japan and revenues amounted to SEK 40 million. The new customers in the fourth quarter were centers with conventional linear accelerators for photon radiotherapy.
Japan is at the forefront of advanced radiotherapy techniques. In addition to treatment planning for photon and electron treatments, RayStation is also used in Japan for protons, carbon ions and BNCT (Boron Neutron Capture Therapy). RayStation's advanced functions and support for many different modalities have been a success factor in the Japanese market.
Johan Löf, founder and CEO, RaySearch, says: "Japan is an important market for RaySearch and the fact that an impressive number of Japanese radiotherapy centers have chosen RayStation as one of their tools in the fight against cancer shows that there is great confidence in our products. We are committed to continue developing innovative software for ever better and more advanced cancer treatments."
Johan Löf, founder and CEO, RaySearch Laboratories AB (publ)
Telephone: +46 (0) 8 510 530 00
johan.lof@raysearchlabs.com
Henrik Bergentoft, CFO, RaySearch Laboratories AB (publ)
Telephone: +46 (0) 8 510 530 00
henrik.bergentoft@raysearchlabs.com (henrik.bergentoft@raysearchlabs.com)